Panbela Therapeutics

-$0.01 (-0.25%) As of 6:55 PM UTC today

Why Robinhood?

You can buy or sell PBLA and other stocks, options, and ETFs commission-free!

About PBLA

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis.

CEO
Jennifer K. Simpson
Employees
6
Headquarters
Waconia, Minnesota
Founded
2011

PBLA Key Statistics

Market Cap
39.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
90.43K
High Today
$4.21
Low Today
$4.00
Open Price
$4.04
Volume
22.14K
52 Week High
$10.00
52 Week Low
$2.37

PBLA Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
—

You May Also Like

AFRM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure